New insights into acute-on-chronic kidney disease in nephrology patients: the CKD-REIN study
Aghilès Hamroun(Université de Lille), Mustafa Smati, Denis Fouque(Université Claude Bernard Lyon 1), Bruno Moulin(Université de Strasbourg), Éric Magnant, Thierry Lobbedez, Bruce Robinson(University of Michigan), Marie Metzger, Sébastien Mailliez, Carole Ayav(Inserm), Sophie Liabeuf(Centre Hospitalier Universitaire Amiens-Picardie), Christian Jacquelinet(Université Paris-Sud), Dorothée Cannet, Jean Philippe Bourdenx, Jarcy Zee(Children's Hospital of Philadelphia), Gaëtan Lebrun(Assistance Publique – Hôpitaux de Paris), Gabriel Choukroun(Centre Hospitalier Universitaire Amiens-Picardie), Hacène Sekhri, Benjamin Deroure, Bénédicte Stengel(Inserm), Ziad A. Massy(Inserm), Élodie Speyer, Adeline Lacraz(Centre Hospitalier Universitaire de Bordeaux), Luc Frimat(Centre Hospitalier Régional et Universitaire de Nancy), Marie Essig, François Glowacki(Centre National de la Recherche Scientifique), Raymond Azar, Maurice Laville(Lyon 1 Université), Serge Briançon, Céline Lange, Christophe Pascal, G Lambrey, Karine Legrand, Yves-Édouard Herpe, Prs Thierry Hannedouche, Christian Combe(Université de Bordeaux)
Cited by 16
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
|JAMA|2014|982
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766